You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 152 No. 8, AUGUST 1992 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL OBSERVATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Isolated Corticotropin Deficiency in Adults

Report of 10 Cases and Review of Literature

Toshihide Yamamoto, MD; Jiro Fukuyama, MD; Kyoichi Hasegawa, MD; Masahiko Sugiura, PhD

Arch Intern Med. 1992;152(8):1705-1712.


Abstract



The clinical and laboratory findings in 76 patients with isolated corticotropin deficiency (10 of our own and 66 from literature) were analyzed with the following observations. With the exceptions of hyperpigmentation and hyperkalemia, the similarity of symptoms and signs to those of Addison's disease and their reversibility by glucocorticoids indicate that most, but not all, manifestation of isolated corticotropin deficiency is caused by glucocorticoid deficiency. Isolated corticotropin deficiency seems to be of pituitary origin in most patients, as shown by lack of corticotropin response to insulin-induced hypoglycemia, vasopressin, or corticotropin-releasing factor. Secretion of other pituitary hormones is frequently abnormal, which is mostly attributable to glucocorticoid deficiency. Although the pathogenesis of isolated corticotropin deficiency is unknown in most patients, association with other autoimmune endocrinopathies, postpartum onset in women, or serum antipituitary antibodies suggests an autoimmune pathogenesis in some patients. In two of our 10 patients, cancer developed during glucocorticoid treatment. More observations of complications and long-term prognosis following glucocorticoid therapy are needed for optimal clinical decision making.

(Arch Intern Med. 1992;152:1705-1712)



Author Affiliations



From the Department of Medicine, Kishiwada Tokushukai Hospital, Osaka, Japan (Dr Yamamoto); Chigasaki (Japan) Tokushukai Hospital (Dr Fukuyama); Center for Adult Diseases, Osaka (Dr Hasegawa); and Biomedical Laboratories Inc, Kawagoe, Japan (Dr Sugiura).


Footnotes



Accepted for publication December 16, 1991.

Reprint requests to Department of Medicine, Kishiwada Tokushukai Hospital, 4-22-38 Isonokami-cho, Kishiwada, Osaka 596, Japan (Dr Yamamoto).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis
Engler et al.
Endocr Rev 1999;20:460-500.
ABSTRACT | FULL TEXT  

Case report: confusion responding to dexamethasone in a patient with cancer of the prostate
Wilcock and Twycross
Palliat Med 1995;9:337-338.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.